通过宏基因组学研究肠道微生物对结直肠癌患者影响的最新进展

doi:10.11904/j.issn.1002-3070.2020.01.018

实用肿瘤学杂志 ›› 2020, Vol. 34 ›› Issue (1): 93-96.doi: 10.11904/j.issn.1002-3070.2020.01.018

• 综述 • 上一篇

通过宏基因组学研究肠道微生物对结直肠癌患者影响的最新进展

李智杰, 赵琦, 吴华星

哈尔滨医科大学附属肿瘤医院腔镜科(哈尔滨 150081)

收稿日期:2019-08-06 修回日期:2019-11-06 出版日期:2020-02-28 发布日期:2020-02-20
通讯作者: 吴华星,E-mail:107178265@qq.com
作者简介:李智杰,女,(1993-),硕士研究生,从事内窥镜诊断及治疗方面的研究。

Research progress in the effects of intestinal microbes on colorectal cancer patients by metagenomics

LI Zhijie, ZHAO Qi, WU Huaxing

Endoscopy Room,Harbin Medical University Cancer Hospital,Harbin 150081,China

Received:2019-08-06 Revised:2019-11-06 Online:2020-02-28 Published:2020-02-20

摘要/Abstract

摘要： 人类肠道微生物已越来越受到医学界的广泛关注,人类肠道微生物不仅在人类健康方面,而且在人类疾病的发生和发展方面都有很大的作用。人们不断发现微生物与癌症之间的联系,特别是肠道微生物群和肠道肿瘤之间的联系。宏基因组学作为微生物研究的一种重要研究方法,在微生物与结直肠癌研究中发挥越来越重要的作用。近年来,通过宏基因组学研究肠道微生物菌群的变化为结直肠癌的发生和发展提供了新的见解,并且强调了癌症微生物群中宿主-微生物和微生物间相互作用的重要性。本综述回顾了通过宏基因组学研究肠道微生物与结直肠癌之间的关系,希望为癌症预防、诊断和治疗提供新的机会。

关键词: 肠道微生物, 结直肠癌, 宏基因组学

Abstract: Human gut microbes have received increasing attention in the medical community,and they have a great role not only in human health,but also in the occurrence and development of human diseases.The link between microbes and cancer,especially between the gut microbiota and intestinal tumors,is constantly being discovered.Metagenomics,as an important research method in microbial research,plays an increasingly important role in the study of microbial and colorectal cancer.In recent years,the study of gut microbiota by metagenomics has provided new insights into the development and progression of colorectal cancer,which emphasize the importance of host-microbe and microbial interactions in cancer microbiota.This article reviews the relationship between gut microbiota and colorectal cancer through metagenomics,and is expected to open up new opportunities for prevention,diagnosis and treatment of cancer.

Key words: Intestinal microbes, Colorectal cancer, Metagenomics

中图分类号:

R735.3

李智杰, 赵琦, 吴华星. 通过宏基因组学研究肠道微生物对结直肠癌患者影响的最新进展[J]. 实用肿瘤学杂志, 2020, 34(1): 93-96.

LI Zhijie, ZHAO Qi, WU Huaxing. Research progress in the effects of intestinal microbes on colorectal cancer patients by metagenomics[J]. Journal of Practical Oncology, 2020, 34(1): 93-96.

参考文献

1 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
2 Arnold M,Sierra MS,Laversanne M,et al.Global patterns and trends in colorectal cancer incidence and mortality[J].Gut,2017,66(4):683-691.
3 Picardo SL,Coburn B,Hansen AR.The microbiome and cancer for clinicians[J].Crit Rev Oncol Hematol,2019,141:1-12.
4 Handelsman J,Rondon MR,Brady SF,et al.Molecular biological access to the chemistry of unknown soil microbes:a new frontier for natural products[J].Chem Biol,1998,5(10):245-249.
5 李凤,李艳萍,张小蒙.宏基因组学的研究方法进展及应用概述[J].生物技术世界,2015,89(4):9-10.
6 Chiu CY,Miller SA.Clinical metagenomics[J].Nat Rev Genet,2019,20(6):341-355.
7 Chu DM,Seferovic M,Pace RM,et al.The microbiome in preterm birth[J].Best Pract Res Clin Obstet Gynaecol,2018,52:103-113.
8 熊晓平,陈修己,熊敦勇.胃癌及癌前病变中幽门螺杆菌与p53基因表达关系的研究[J].实用肿瘤学杂志,2003,17(3):84-186.
9 Grivennikov SI,Wang K,Mucida D,et al.Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth[J].Nature,2012,491(7423):254-258.
10 Chen J,Pitmon E,Wang K.Microbiome,inflammation and colorectal cancer[J].Semin Immunol,2017,32:43-53.
11 Karin M,Greten FR.NF-kappaB:linking inflammation and immunity to cancer development and progression[J].Nat Rev Immunol,2005,5(10):749-759.
12 Louis P,Hold GL,Flint HJ.The gut microbiota,bacterial metabolites and colorectal cancer[J].Nat Rev Microbiol,2014,12(10):661-672.
13 Almeida A,Mitchell AL,Boland M,et al.A new genomic blueprint of the human gut microbiota[J].Nature,2019,568(7753):499-504.
14 Qin J,Li R Raes J,et al. A human gut microbial gene catalogue established by metagenomic sequencing[J].Nature,2010,464:59-65.
15 Thomas AM,Manghi P,Asnicar F,et al.Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation[J].Nat Med,2019,25(4):667-678.
16 Dai Z,Coker OO,Nakatsu G,et al.Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers[J].Microbiome,2018,6(1):70.
17 Goodwin AC,Destefano Shields CE,Wu S,et al.Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis[J].Proc Natl Acad Sci U S A,2011,108(37):15354-15359.
18 Wu J,Li Q,Fu X.Fusobacterium nucleatum contributes to the carcinogenesis of colorectal cancer by inducing inflammation and suppressing host immunity[J].Transl Oncol,2019,12(6):846-851.
19 Ahn J,Sinha R,Pei Z,et al.Human gut microbiome and risk for colorectal cancer[J].J Natl Cancer Inst,2013,105(24):1907-1911.
20 Yu J,Feng Q,Wong SH,et al.Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer[J].Gut,2017,66(1):70-78.
21 Gur C,Ibrahim Y,Isaacson B,et al.Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack[J].Immunity,2015,42(2):344-355.
22 Whitmore SE,Lamont RJ.Oral bacteria and cancer[J].PLoS Pathogens,2014,10(3):e1003933.
23 Sender R,Fuchs S,Milo R,et al.Revised estimates for the number of human and bacteria cells in the body[J].PLoS Biol,2016,14(8):e1002533.
24 Richard ML,Sokol H.The gut mycobiota:insights into analysis,environmental interactions and role in gastrointestinal diseases[J].Nat Rev gastroenterol Hepatol,2019,16(6):331-345.
25 Luan C,Xie L,Yang X,et al.Dysbiosis of fungal microbiota in the intestinal mucosa of patients with colorectal adenomas[J].Sci Rep,2015,5(1):7980.
26 Nash AK,Auchtung TA,Wong MC,et al.The gut mycobiome of the Human Microbiome Project healthy cohort[J].Microbiome,2017,5(1):153.
27 Hallen-Adams HE,Kachman SD,Kim J,et al.Fungi inhabiting the healthy human gastrointestinal tract:a diverse and dynamic community[J].Fungal Ecol,2015,15:9-17.
28 Hallen-Adams HE,Suhr MJ.Fungi in the healthy human gastrointestinal tract[J].Virulence,2017,8(3):352-358.
29 Suhr MJ,Hallen-Adams HE.The human gut mycobiome:pitfalls and potentials-a mycologist′s perspective[J].Mycologia,2015,107(6):1057-1073.
30 Coker OO,Nakatsu G,Dai RZ,et al.Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer[J].Gut,2019,68(4):654-662.

[1]	曾理, 庄树彤, 丁世华, 陈冲, 焦璐, 孙大勇. 长链非编码RNA AFAP1-AS1通过PTEN/p-AKT信号通路调控结直肠癌细胞增殖的分子机制研究[J]. 实用肿瘤学杂志, 2020, 34(1): 11-16.
[2]	廖代祥, 郑博, 张彦斌, 于军辉. RRBP1与RABEX-5蛋白在结直肠癌组织中的表达及与临床病理特征和预后的关系[J]. 实用肿瘤学杂志, 2020, 34(1): 43-48.
[3]	张景岚, 刘瑞宝. 结直肠癌肝转移瘤局部介入治疗应用进展[J]. 实用肿瘤学杂志, 2020, 34(1): 79-82.
[4]	夏天一, 张博淼, 姚克非, 崔滨滨. PTPN9表达水平与结直肠癌的临床关系研究[J]. 实用肿瘤学杂志, 2019, 33(5): 415-419.
[5]	方瑄, 陈洪生, 李国东刘明. 异常隐窝灶治疗的研究进展[J]. 实用肿瘤学杂志, 2019, 33(4): 376-379.
[6]	方琳, 刘超, 张纯慧, 张艳桥. 转移性结直肠癌维持治疗的研究现状与治疗策略[J]. 实用肿瘤学杂志, 2019, 33(2): 173-178.
[7]	佟广海, 田洋, 吴华星. 脂质组学在结直肠癌研究中的应用[J]. 实用肿瘤学杂志, 2019, 33(2): 179-192.
[8]	刘恒辰, 张新宇. Toll样受体信号通路作为结直肠癌潜在治疗靶点的研究进展[J]. 实用肿瘤学杂志, 2019, 33(2): 188-192.
[9]	刘宏涛, 张彤彤综述, 刘雁军审校. 肥胖与结直肠癌发病机制的研究进展[J]. 实用肿瘤学杂志, 2018, 32(5): 464-467.
[10]	王志, 刘忠卫, 曾雪芸, 隋明洁, 廖静怡, 李月欢, 黄卫东, 刘国祥. 基于EQ-5D-5L的结直肠癌癌前病变患者健康相关生命质量研究[J]. 实用肿瘤学杂志, 2018, 32(4): 320-326.
[11]	崔雪阳, 邢承忠. 液体活检在结直肠癌领域的研究及应用现状[J]. 实用肿瘤学杂志, 2018, 32(4): 367-370.
[12]	李文琪, 耿敬姝. RAS/RAF突变与MSI状态在结直肠癌治疗中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(4): 371-376.
[13]	张姗姗, 吴华星审校. 代谢组学在结直肠癌诊断中的应用[J]. 实用肿瘤学杂志, 2017, 31(6): 573-576.
[14]	孙丽娜, 赵晓迪综述, 卢瑗瑗, 王新审校. LncRNA与胃肠道肿瘤化疗耐药的研究进展[J]. 实用肿瘤学杂志, 2017, 31(5): 448-453.
[15]	王东亮,戚宁,牟冠男,张月桂. 结直肠癌肿瘤微环境中调节性T细胞CD39、CD73亚群及二者双阳性亚群的临床意义[J]. 实用肿瘤学杂志, 2017, 31(4): 329-334.

通过宏基因组学研究肠道微生物对结直肠癌患者影响的最新进展

Research progress in the effects of intestinal microbes on colorectal cancer patients by metagenomics

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价